Search

Author/Creator Zeman, K

3. 1496PIntracranial activity of ensartinib in patients with anaplastic lymphoma kinase positive (ALK+) non-small cell lung cancer (NSCLC). (23rd October 2018)

Authors:
Wakelee, H; Reckamp, K L; Leal, T A; Patel, S P; Blumenschein, G; Shum, E; Nieva, J; Oxnard, G; Sanborn, R E; Waqar, S; Zeman, K; Dukart, G; Harrow, K; Liang, C; Holzhausen, A; Horn, L
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial. Issue 1 (January 2022)

Authors:
Verma, Subodh; Dhingra, Nitish K; Butler, Javed; Anker, Stefan D; Ferreira, Joao Pedro; Filippatos, Gerasimos; Januzzi, James L; Lam, Carolyn S P; Sattar, Naveed; Peil, Barbara; Nordaby, Matias; Brueckmann, Martina; Pocock, Stuart J; Zannad, Faiez; Packer, Milton; Packer, M; Anker, S; Butler, J; ...
Journal:
Lancet
Issue:
Volume 10:Issue 1(2022)
Page Start:
35
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗